These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34328682)

  • 1. The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia.
    Hulshof HM; Benova B; Krsek P; Kyncl M; Lequin MH; Belohlavkova A; Jezdik P; Braun KPJ; Jansen FE
    Epilepsia Open; 2021 Dec; 6(4):663-671. PubMed ID: 34328682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive MRI features of the epileptogenic zone in children with tuberous sclerosis.
    Jahodova A; Krsek P; Kyncl M; Jezdik P; Kudr M; Komarek V; Jayakar P; Miller I; Resnick T; Duchowny M
    Eur J Radiol; 2014 Apr; 83(4):703-9. PubMed ID: 24447419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited utility of structural MRI to identify the epileptogenic zone in young children with tuberous sclerosis.
    Nijman M; Yang E; Jaimes C; Prohl AK; Sahin M; Krueger DA; Wu JY; Northrup H; Stone SSD; Madsen JR; Fallah A; Blount JP; Weiner HL; Grayson L; Bebin EM; Porter BE; Warfield SK; Prabhu SP; Peters JM;
    J Neuroimaging; 2022 Sep; 32(5):991-1000. PubMed ID: 35729081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray-matter-specific MR imaging improves the detection of epileptogenic zones in focal cortical dysplasia: A new sequence called fluid and white matter suppression (FLAWS).
    Chen X; Qian T; Kober T; Zhang G; Ren Z; Yu T; Piao Y; Chen N; Li K
    Neuroimage Clin; 2018; 20():388-397. PubMed ID: 30128277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
    Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions.
    Gruber VE; Luinenburg MJ; Colleselli K; Endmayr V; Anink JJ; Zimmer TS; Jansen F; Gosselaar P; Coras R; Scholl T; Blumcke I; Pimentel J; Hainfellner JA; Höftberger R; Rössler K; Feucht M; van Scheppingen J; Aronica E; Mühlebner A
    Epilepsia; 2022 Feb; 63(2):364-374. PubMed ID: 34904712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated cortical tuber in an infant with genetically confirmed tuberous sclerosis complex 1 presenting with symptomatic West syndrome.
    Miyata H; Fushimi S; Ota Y; Vinters HV; Adachi K; Nanba E; Akiyama T
    Neuropathology; 2021 Feb; 41(1):58-64. PubMed ID: 33181865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of a Solitary Cortical Tuber with No Other Manifestations of Tuberous Sclerosis Complex Mimicking Focal Cortical Dysplasia Type II with Calcification.
    Hosomoto K; Sasaki T; Kawai K; Okazaki Y; Hyodo Y; Shibata T; Sasada S; Yasuhara T; Kobayashi K; Yanai H; Date I
    Acta Med Okayama; 2022 Jun; 76(3):323-328. PubMed ID: 35790363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH; Mahadeo T; Bordey A
    J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct microRNA expression profile is associated with α[
    Bagla S; Cukovic D; Asano E; Sood S; Luat A; Chugani HT; Chugani DC; Dombkowski AA
    Neurobiol Dis; 2018 Jan; 109(Pt A):76-87. PubMed ID: 28993242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epileptogenicity in tuberous sclerosis complex: A stereoelectroencephalographic study.
    Neal A; Ostrowsky-Coste K; Jung J; Lagarde S; Maillard L; Kahane P; Touraine R; Catenoix H; Montavont A; Isnard J; Arzimanoglou A; Bartolomei F; Guenot M; Rheims S
    Epilepsia; 2020 Jan; 61(1):81-95. PubMed ID: 31860139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmantle sign in focal cortical dysplasia: a unique radiological entity with excellent prognosis for seizure control.
    Wang DD; Deans AE; Barkovich AJ; Tihan T; Barbaro NM; Garcia PA; Chang EF
    J Neurosurg; 2013 Feb; 118(2):337-44. PubMed ID: 23216463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Early MRI Characteristics With Subsequent Epilepsy and Neurodevelopmental Outcomes in Children With Tuberous Sclerosis Complex.
    Hulshof HM; Kuijf HJ; Kotulska K; Curatolo P; Weschke B; Riney K; Krsek P; Feucht M; Nabbout R; Lagae L; Jansen A; Otte WM; Lequin MH; Sijko K; Benvenuto A; Hertzberg C; Benova B; Scholl T; De Ridder J; Aronica EMA; Kwiatkowski DJ; Jozwiak S; Jurkiewicz E; Braun K; Jansen FE;
    Neurology; 2022 Mar; 98(12):e1216-e1225. PubMed ID: 35101906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex.
    Mühlebner A; van Scheppingen J; Hulshof HM; Scholl T; Iyer AM; Anink JJ; van den Ouweland AM; Nellist MD; Jansen FE; Spliet WG; Krsek P; Benova B; Zamecnik J; Crino PB; Prayer D; Czech T; Wöhrer A; Rahimi J; Höftberger R; Hainfellner JA; Feucht M; Aronica E
    PLoS One; 2016; 11(6):e0157396. PubMed ID: 27295297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
    Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development, focal cortical dysplasia or TSC-related cortical tubers.
    Veersema TJ; de Neef A; van Scheppingen J; Ferrier CH; van Eijsden P; Gosselaar PH; van Rijen PC; Spliet WGM; Braun KPJ; Mühlebner A; Aronica E
    Int J Dev Neurosci; 2019 Dec; 79():96-104. PubMed ID: 31770571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of MRI features and surgical outcome among the subtypes of focal cortical dysplasia.
    Kim DW; Kim S; Park SH; Chung CK; Lee SK
    Seizure; 2012 Dec; 21(10):789-94. PubMed ID: 23040369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive model for epileptogenic tubers from all tubers in patients with tuberous sclerosis complex based on
    Wang Z; Li Y; He Z; Li S; Huang K; Shi X; Sun X; Ruan R; Cui C; Wang R; Wang L; Lv S; Zhang C; Liu Z; Yang H; Yang X; Liu S
    BMC Med; 2023 Dec; 21(1):500. PubMed ID: 38110931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphometric MRI analysis enhances visualization of cortical tubers in tuberous sclerosis.
    House PM; Holst B; Lindenau M; Voges B; Kohl B; Martens T; Lanz M; Stodieck S; Huppertz HJ
    Epilepsy Res; 2015 Nov; 117():29-34. PubMed ID: 26370915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.